Add to ORKGCurrent evidence-based management for clinically localised prostate cancer includes active surveillance, surgery, external beam radiotherapy (EBRT) and brachytherapy. The impact of these treatment modalities on quality of life (QoL) is uncertain.status: publishe
Objective: Due to a lack of evidence from randomised studies, there is little agreement on the best ...
textabstractIn Western countries prostate cancer is the most prevalent malignancy in males. In its e...
Since prostate cancer prevalence is so high, multiple treatment modalities have been developed, with...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Aims and Objective: Monotherapy for localised prostate cancer with radical prostatectomy, external b...
Purpose Earlier studies evaluating the effect on quality of life (QoL) of localized prostate cancer ...
Abstract Purpose Prostate cancer is the leading form of cancer diagnosed among North American men. M...
Background:Previous studies on the effects of different prostate cancer treatments on quality of lif...
Background: Localized prostate cancer (PCa) treatment is associated with reduced health-related qual...
Objective: Due to a lack of evidence from randomised studies, there is little agreement on the best ...
textabstractIn Western countries prostate cancer is the most prevalent malignancy in males. In its e...
Since prostate cancer prevalence is so high, multiple treatment modalities have been developed, with...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Aims and Objective: Monotherapy for localised prostate cancer with radical prostatectomy, external b...
Purpose Earlier studies evaluating the effect on quality of life (QoL) of localized prostate cancer ...
Abstract Purpose Prostate cancer is the leading form of cancer diagnosed among North American men. M...
Background:Previous studies on the effects of different prostate cancer treatments on quality of lif...
Background: Localized prostate cancer (PCa) treatment is associated with reduced health-related qual...
Objective: Due to a lack of evidence from randomised studies, there is little agreement on the best ...
textabstractIn Western countries prostate cancer is the most prevalent malignancy in males. In its e...
Since prostate cancer prevalence is so high, multiple treatment modalities have been developed, with...